Clinical trial
Bupivicaine Extended-Release Liposome Injection Versus Marcaine for Early Post-Operative Pain Control Following Wrist Operations
NCT02052180 is registered in ClinicalTrials.gov with University of Tennessee as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bupivicaine Extended-Release Liposome Injection Versus Marcaine for Early Post-Operative Pain Control Following Wrist Operations
- Lead sponsor
- University of Tennessee
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 31, 2013
- Completion date
- May 31, 2014
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.